Using New Ultrasound Techniques to Assess Peritoneal Fibrosis in Peritoneal Dialysis Patients

December 14, 2022 updated by: Na Jiang, Shanghai Jiao Tong University School of Medicine

An Exploratory Study Using New Ultrasound Techniques to Assess Peritoneal Fibrosis and Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients

Explore the role of new ultrasound techniques in the assessment of peritoneal fibrosis and encapsulating peritoneal sclerosis in peritoneal dialysis patients

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Anticipated)

210

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200001
        • Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 71 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

End-stage renal diseases(ESRD) patients on PD

Description

Inclusion Criteria:

  • ESRD patients on PD
  • PD duration ≤12 months or ≥10 years
  • Age between 18-75years

Exclusion Criteria:

  • Refusing to sign up informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
short-term peritoneal dialysis
the time of treatment of peritoneal dialysis less 12 months
long-term peritoneal dialysis
the time of treatment of peritoneal dialysis more than 10 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
parietal peritoneal fibrosis
Time Frame: the 1 day when being recruited
Ultrasonography evaluates parietal peritoneal fibrosis, including parameters such as thickness, stiffness, elasticity, and blood supply.
the 1 day when being recruited

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
encapsulting peritoneal sclerosis
Time Frame: the 1 day when being recruited
Ultrasonography assesses for encapsulting peritoneal sclerosis.
the 1 day when being recruited

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

December 8, 2022

First Submitted That Met QC Criteria

December 14, 2022

First Posted (Estimate)

December 15, 2022

Study Record Updates

Last Update Posted (Estimate)

December 15, 2022

Last Update Submitted That Met QC Criteria

December 14, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • new ultrasound technology

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peritoneal Sclerosis

Subscribe